These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 18397392)

  • 1. Eliminating lymphatic filariasis--the surveillance challenge.
    Huppatz C; Durrheim D; Lammie P; Kelly P; Melrose W
    Trop Med Int Health; 2008 Mar; 13(3):292-4. PubMed ID: 18397392
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphatic filariasis elimination in the Pacific: PacELF replicating Japanese success.
    Ichimori K; Graves PM; Crump A
    Trends Parasitol; 2007 Jan; 23(1):36-40. PubMed ID: 17126604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress towards, and challenges for, the elimination of filariasis from Pacific-island communities.
    Burkot TR; Taleo G; Toeaso V; Ichimori K
    Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S61-9. PubMed ID: 12625919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [ Bancroftian lymphatic filariasis: toward its elimination from the Pacific?].
    Chanteau S; Roux JF
    Bull Soc Pathol Exot; 2008 Jun; 101(3):254-60. PubMed ID: 18681220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: Global elimination of lymphatic filariasis: fact or fantasy?
    Gyapong JO; Twum-Danso NA
    Trop Med Int Health; 2006 Feb; 11(2):125-8. PubMed ID: 16451335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global programme to eliminate lymphatic filariasis: progress report, 2011.
    Wkly Epidemiol Rec; 2012 Sep; 87(37):346-56. PubMed ID: 22977953
    [No Abstract]   [Full Text] [Related]  

  • 7. Certifying lymphatic filariasis elimination in the Pacific--the need for new tools.
    Durrheim DN; Nelesone T; Speare R; Melrose W
    Pac Health Dialog; 2003 Sep; 10(2):149-54. PubMed ID: 18181427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass drug administration to eliminate lymphatic filariasis in India.
    Ramaiah KD; Das PK
    Trends Parasitol; 2004 Nov; 20(11):499-502. PubMed ID: 15471698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress towards eliminating lymphatic filariasis in Zanzibar: a model programme.
    Mohammed KA; Molyneux DH; Albonico M; Rio F
    Trends Parasitol; 2006 Jul; 22(7):340-4. PubMed ID: 16713740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of mass drug administration on elimination of lymphatic filariasis in Surat city, India.
    Vaishnav KG; Desai HS; Srivastava PK; Joshi PT; Kurian G; Thakor HG; Dhariwal AC
    J Commun Dis; 2012 Dec; 44(4):251-9. PubMed ID: 25145075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global Programme to eliminate lymphatic filariasis: progress report on mass drug administration, 2010.
    Wkly Epidemiol Rec; 2011 Aug; 86(35):377-88. PubMed ID: 21887884
    [No Abstract]   [Full Text] [Related]  

  • 12. The end of lymphatic filariasis?
    Bockarie MJ; Molyneux DH
    BMJ; 2009 May; 338():b1686. PubMed ID: 19439451
    [No Abstract]   [Full Text] [Related]  

  • 13. Lymphatic filariasis in the Eastern Mediterranean Region: current status and prospects for elimination.
    El Setouhy M; Ramzy RM
    East Mediterr Health J; 2003 Jul; 9(4):534-41. PubMed ID: 15748050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global programme to eliminate lymphatic filariasis: progress report for 2012.
    Wkly Epidemiol Rec; 2013 Sep; 88(37):389-99. PubMed ID: 24073461
    [No Abstract]   [Full Text] [Related]  

  • 15. Knowledge on lymphatic filariasis and mass drug administration (MDA) programme in filaria endemic districts of Andhra Pradesh, India.
    Mukhopadhyay AK; Patnaik SK; Satya Babu P; Rao KN
    J Vector Borne Dis; 2008 Mar; 45(1):73-5. PubMed ID: 18399322
    [No Abstract]   [Full Text] [Related]  

  • 16. Launching a lymphatic filariasis campaign in the Pacific Islands.
    Dean M
    Lancet; 2000 Jul; 356(9224):143. PubMed ID: 10963257
    [No Abstract]   [Full Text] [Related]  

  • 17. Global programme to eliminate lymphatic filariasis.
    Wkly Epidemiol Rec; 2010 Sep; 85(38):365-72. PubMed ID: 20853547
    [No Abstract]   [Full Text] [Related]  

  • 18. Adverse reactions following mass drug administration during the Programme to Eliminate Lymphatic Filariasis in Orissa State, India.
    Babu BV; Rath K; Kerketta AS; Swain BK; Mishra S; Kar SK
    Trans R Soc Trop Med Hyg; 2006 May; 100(5):464-9. PubMed ID: 16288792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing morbidity and preventing disability in the Global Programme to Eliminate Lymphatic Filariasis: WHO position statement.
    Wkly Epidemiol Rec; 2011 Dec; 86(51-52):581-5. PubMed ID: 22191103
    [No Abstract]   [Full Text] [Related]  

  • 20. Global programme to eliminate lymphatic filariasis: progress report, 2015.
    Wkly Epidemiol Rec; 2016 Sep; 91(39):441-55. PubMed ID: 27758091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.